NO20024325D0 - Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use - Google Patents
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic useInfo
- Publication number
- NO20024325D0 NO20024325D0 NO20024325A NO20024325A NO20024325D0 NO 20024325 D0 NO20024325 D0 NO 20024325D0 NO 20024325 A NO20024325 A NO 20024325A NO 20024325 A NO20024325 A NO 20024325A NO 20024325 D0 NO20024325 D0 NO 20024325D0
- Authority
- NO
- Norway
- Prior art keywords
- diagnostic
- therapeutic use
- envelope proteins
- virus envelope
- purified hepatitis
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26066901P | 2001-01-11 | 2001-01-11 | |
| US31576801P | 2001-08-30 | 2001-08-30 | |
| PCT/EP2002/000219 WO2002055548A2 (en) | 2001-01-11 | 2002-01-11 | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024325D0 true NO20024325D0 (en) | 2002-09-10 |
| NO20024325L NO20024325L (en) | 2002-11-11 |
Family
ID=26948130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024325A NO20024325L (en) | 2001-01-11 | 2002-09-10 | Purified hepatitis C virus envelope proteins for diagnosis and therapeutic use |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1463753A2 (en) |
| KR (1) | KR20020089371A (en) |
| CN (1) | CN1547588A (en) |
| AR (1) | AR032240A1 (en) |
| AU (1) | AU2002238502B2 (en) |
| BR (1) | BR0203518A (en) |
| CA (1) | CA2400643A1 (en) |
| CZ (1) | CZ20032164A3 (en) |
| HU (1) | HUP0302416A2 (en) |
| IL (1) | IL151033A0 (en) |
| MX (1) | MXPA02008886A (en) |
| NO (1) | NO20024325L (en) |
| PL (1) | PL363175A1 (en) |
| RU (1) | RU2313363C2 (en) |
| TR (1) | TR200202169T1 (en) |
| WO (1) | WO2002055548A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03009626A (en) | 2001-04-24 | 2004-06-30 | Innogenetics Nv | Constructs and methods for expression of recombinant hcv envelope proteins. |
| WO2004041853A2 (en) * | 2002-11-08 | 2004-05-21 | Innogenetics N.V. | Hcv vaccine compositions comprising e1 and ns3 peptides |
| EP1561470A1 (en) * | 2003-06-20 | 2005-08-10 | Innogenetics N.V. | HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| JP4342519B2 (en) * | 2003-09-22 | 2009-10-14 | 株式会社グリーンペプタイド | Hepatitis C virus-derived peptide |
| CN100365124C (en) * | 2005-10-27 | 2008-01-30 | 云南大学 | Determination and application of hepatitis C virus specific cDNA sequence |
| CN115980352A (en) * | 2022-12-30 | 2023-04-18 | 宁波博肽生物技术有限公司 | A kind of HCV antigen coating pretreatment agent, antigen coating method and detection kit |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1845108A3 (en) * | 1994-07-29 | 2007-10-24 | Innogenetics N.V. | Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
-
2002
- 2002-01-11 EP EP02704649A patent/EP1463753A2/en not_active Withdrawn
- 2002-01-11 RU RU2002121632/15A patent/RU2313363C2/en not_active IP Right Cessation
- 2002-01-11 CA CA002400643A patent/CA2400643A1/en not_active Abandoned
- 2002-01-11 TR TR2002/02169T patent/TR200202169T1/en unknown
- 2002-01-11 HU HU0302416A patent/HUP0302416A2/en unknown
- 2002-01-11 CN CNA028006097A patent/CN1547588A/en active Pending
- 2002-01-11 PL PL02363175A patent/PL363175A1/en unknown
- 2002-01-11 CZ CZ20032164A patent/CZ20032164A3/en unknown
- 2002-01-11 BR BR0203518-9A patent/BR0203518A/en not_active IP Right Cessation
- 2002-01-11 WO PCT/EP2002/000219 patent/WO2002055548A2/en not_active Ceased
- 2002-01-11 IL IL15103302A patent/IL151033A0/en unknown
- 2002-01-11 AU AU2002238502A patent/AU2002238502B2/en not_active Ceased
- 2002-01-11 MX MXPA02008886A patent/MXPA02008886A/en active IP Right Grant
- 2002-01-11 KR KR1020027011431A patent/KR20020089371A/en not_active Abandoned
- 2002-01-14 AR ARP020100104A patent/AR032240A1/en unknown
- 2002-09-10 NO NO20024325A patent/NO20024325L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002238502B2 (en) | 2007-09-06 |
| CA2400643A1 (en) | 2002-07-18 |
| MXPA02008886A (en) | 2003-04-25 |
| TR200202169T1 (en) | 2004-06-21 |
| RU2002121632A (en) | 2004-03-20 |
| AR032240A1 (en) | 2003-10-29 |
| KR20020089371A (en) | 2002-11-29 |
| WO2002055548A3 (en) | 2004-08-05 |
| NO20024325L (en) | 2002-11-11 |
| WO2002055548A8 (en) | 2002-10-31 |
| CN1547588A (en) | 2004-11-17 |
| RU2313363C2 (en) | 2007-12-27 |
| AU2002238502A1 (en) | 2002-07-24 |
| CZ20032164A3 (en) | 2003-10-15 |
| IL151033A0 (en) | 2003-04-10 |
| HUP0302416A2 (en) | 2003-10-28 |
| EP1463753A2 (en) | 2004-10-06 |
| AU2002238502B9 (en) | 2002-07-24 |
| WO2002055548A2 (en) | 2002-07-18 |
| BR0203518A (en) | 2002-12-17 |
| PL363175A1 (en) | 2004-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1414471T3 (en) | Therapeutic agents comprising pro-apoptotic proteins | |
| NO20044192L (en) | 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations | |
| LU91328I2 (en) | Human papillomavirus vaccine Ätypes 6,11,16,18Ü (recombinant, adsorbed) | |
| NO20030832L (en) | Condensed cyclic compounds and their medical use | |
| ATE315938T1 (en) | 4'-SUBSTITUTED NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS C VIRUS-MEDIATED DISEASES | |
| DK1054955T3 (en) | Compositions comprising viruses and methods for concentrating virus preparations | |
| NO20033556D0 (en) | Pharmaceutical preparations | |
| ATE275631T1 (en) | RECOMBINANT VENEZOLAN EQUINE EQUINO CEPHALITIS VIRUS VACCINE | |
| DE60237823D1 (en) | MEDICAL TREATMENT INSTRUMENT | |
| EP1307130A4 (en) | VACCINE AGAINST HUMAN IMMUNE WEAK VIRUS | |
| DE50209220D1 (en) | Medical forceps | |
| IL162236A0 (en) | Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use | |
| IS7830A (en) | Hepatitis C virus (HCV) vaccine | |
| NO20040249L (en) | Blood group antigen fusion polypeptides and methods for their use | |
| DE60008906D1 (en) | MEDICAL PLIERS | |
| DK1417189T3 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
| DK1265577T3 (en) | Medical or dental medical treatment chair | |
| NO20033506D0 (en) | Parasite-killing preparations and methods of use | |
| NO20033829L (en) | Virus killing preparations | |
| EP1425039A4 (en) | IMMUNOREACTIVE PEPTIDES OF HUMAN PAPILLOMAVIRUS | |
| IS5777A (en) | Vaccine hepatitis B virus variants and its use | |
| NO20024325D0 (en) | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | |
| ATE437656T1 (en) | VACCINE AGAINST FORAL ACID VIRUS | |
| NO20033120D0 (en) | 2-arylimino-2,3-dihydrotiazole derivatives, processes for their preparation and therapeutic use thereof | |
| ATA3922001A (en) | MEDICAL ELECTRODE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |